J 247 (Lamotrigine 150 mg)
Pill with imprint J 247 is White, Round and has been identified as Lamotrigine 150 mg. It is supplied by Cadista.
Lamotrigine is used in the treatment of bipolar disorder; seizure prevention; schizoaffective disorder; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for J 247
Lamotrigine
- Imprint
- J 247
- Strength
- 150 mg
- Color
- White
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cadista
- Inactive Ingredients
-
lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 59746-0247 | Jubilant Cadista Pharmaceuticals Inc. |
| 42291-0368 | AvKare, Inc. |
More about lamotrigine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1312 Reviews
- Drug class: triazine anticonvulsants
- FDA Alerts (5)
Consumer resources
- Lamotrigine
- Lamotrigine (Advanced Reading)
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Tablets
Other brands: Lamictal, Lamictal XR, Subvenite, Lamictal CD, Lamictal ODT
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
